Re: Farmas USA
No la sigo pero supongo que aqui encontraras las respuestas que buscas a lo de hoy
TG Therapeutics' (TGTX) CEO Mike Weiss on Q2 2014 Results - Earnings Call Transcript
TGTX
------------
Por cierto, hoy 3 upgrades
TG Therapeutics's PT raised by Roth Capital to $25.00. buy rating
TG Therapeutics's PT raised by Brean Capital to $19.00. buy rating
Roth Capital Boosts Price Target on TG Therapeutics ($TGTX) to $25 on Prelim. TG-1101 Phase 1 Data